July 04, 2025 a 07:43 pm

WAT: Fundamental Ratio Analysis - Waters Corporation

Waters Corporation Stock Analysis

The Waters Corporation (WAT) provides analytical workflow solutions globally. It has a strong market presence in the healthcare sector, specializing in diagnostics and research. The stock is currently under analyst focus due to its innovative product solutions in high-performance instrumentation.

Fundamental Rating

Waters Corporation has been assigned a fundamental rating of B+. The scores offer insight into the company's valuation metrics, including discounted cash flow, return on equity, and debt to equity ratio.

Category Score Visual
Discounted Cash Flow 4
Return on Equity 5
Return on Assets 5
Debt to Equity 1
Price to Earnings 2
Price to Book 1

Historical Rating

A comparison of historical ratings offers insights into the company's consistent performance over time.

Date Overall DCF ROE ROA Debt/Equity P/E P/B
2025-07-03 3 4 5 5 1 2 1
NA 0 4 5 5 1 2 1

Analyst Price Targets

The analyst price targets provide insights into the expected market performance of the stock.

High Low Median Consensus
400 374 387 387
Stock Price Chart Responsive

Analyst Sentiment

Analyzing analyst recommendations provides a look into market sentiment towards the stock.

Recommendation Count Visual
Strong Buy 0
Buy 10
Hold 19
Sell 3
Strong Sell 0

Conclusion

Waters Corporation has a strong position in the healthcare diagnostics and research sector, with solid fundamental ratings and consistent scores over time. Analyst sentiment suggests a 'Hold' consensus due to balanced buy and hold positions. Challenges include a moderate debt-to-equity ratio. Investors should consider these factors alongside the industry's growth potential.